Sort
78,016 grants matching “breast cancer”
Project 2: Regulation of Pre-mRNA Splicing in Tumorigenesis
$663,644Adrian R Krainer · Cold Spring Harbor Laboratory · P01 · FY2020 · CA
WHOLE-GENOME SEQUENCING OF HIGH-RISK FAMILIES TO IDENTIFY NEW MUTATIONAL MECHANISMS OF BREAST CANCER PREDISPOSITION
$663,639University Of Washington · · FY2013 · Department of Defense
Assessing Benefits and Harms of Medical Cannabis and Cannabinoid Use in Breast Cancer Patients During and After Treatments
$663,626Jennifer J Hu · University Of Miami School Of Medicine · U01 · FY2023 · CA
Angiogenesis imaging
$663,550Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Data Processing, Analysis and Modeling Unit
$663,501Jeremy Goecks · Oregon Health & Science University · U2C · FY2021 · CA
ER stress-driven IRE1a-XBP1 signaling in lung cancer
$663,481Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
ER stress-driven IRE1a-XBP1 signaling in lung cancer
$663,481Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Use and Outcomes of Radiation Therapy for Medicare Patients with Common Cancers
$663,470Cary P Gross · Yale University · R01 · FY2010 · CA
Leveraging machine learning to improve risk prediction for chemotherapy induced neuropathy
$663,447Alyce Sophia Adams · Kaiser Foundation Research Institute · R01 · FY2020 · CA
Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women
$663,406Joan M Lappe · Creighton University · R01 · FY2013 · CA
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center
$663,338Jason Derek Merker · Univ Of North Carolina Chapel Hill · UG1 · FY2022 · CA
Screening for Free: A Value-Based Insurance Design Natural Experiment
$663,309John Hsu · Massachusetts General Hospital · R01 · FY2012 · CA
MOUSE MODELS OF OVARIAN CANCER
$663,283Fox Chase Cancer Center · U01 · FY2003 · CA
A randomized trial of lifestyle guidelines on breast cancer biomarkers and treatment adherence
$663,278Tara B Sanft · Yale University · R01 · FY2018 · CA
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA
$663,266Miriam C Poirier · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
The role of Cyclin E and Cks proteins in growth control and tumorigenesis
$663,250Steven I Reed · Scripps Research Institute, The · R01 · FY2015 · CA
Cardiovascular Impact of Near-complete Estrogen Deprivation for Breast Cancer
$663,250Alexandra Thomas · Duke University · R01 · FY2024 · HL
The role of Cyclin E and Cks proteins in growth control and tumorigenesis
$663,250Steven I Reed · Scripps Research Institute, The · R01 · FY2014 · CA
Integrating genomic and transcriptomic data to identify breast cancer susceptibility genes
$663,159Wei Zheng · Vanderbilt University Medical Center · R01 · FY2023 · CA
Development of a precision medicine platform for circadian based therapeutics in pancreatic cancer
$663,143Faraz Bishehsari · Rush University Medical Center · R01 · FY2022 · CA
Structurally dissecting APOBEC3's for HIV-1 restriction and beyond
$663,123Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · AI
VEGFR Signaling Controls Lymphatic Junctions
$663,120Joshua Paul Scallan · University Of South Florida · R01 · FY2025 · HL
VEGFR Signaling Controls Lymphatic Junctions
$663,120Joshua Paul Scallan · University Of South Florida · R01 · FY2023 · HL
Single-use Microfluidic Device for Radiopharmaceutical Production
$663,092Henry Charles Manning · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · EB
Synthetic mRNA-mediated reversible immunocontraception
$663,083Philip J Santangelo · Emory University · R33 · FY2023 · HD